Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
IL-17F and IL-17A are members of the IL-17 pro-inflammatory cytokine family. IL-17A has been implicated in the pathogenesis of autoimmune diseases. IL-17F is a disulfide-linked dimer that contains a cysteine-knot motif. We hypothesized that IL-17F and IL-17A could form a heterodimer due to their sequence homology and overlapping pattern of expression. We evaluated the structure of recombinant IL-17F and IL-17A proteins, as well as that of natural IL-17F and IL-17A derived from activated human CD4+ T cells, by enzyme-linked immunosorbent assay, immunoprecipitation followed by Western blotting, and mass spectrometry. We find that both IL-17F and IL-17A can form both homodimeric and heterodimeric proteins when expressed in a recombinant system, and that all forms of the recombinant proteins have in vitro functional activity. Furthermore, we find that in addition to the homodimers of IL-17F and IL-17A, activated human CD4+ T cells also produce the IL-17F/IL-17A heterodimer. These data suggest that the IL-17F/IL-17A heterodimer may contribute to the T cell-mediated immune responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A, -AF and -F trigger qualitatively similar signaling pathways, however IL-17A homodimers induce a far more potent signal compared to IL-17F homodimers, with IL-17AF thought to be intermediate signaling strength”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Wright et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
Cited by
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
“Both are covalent homodimers, and recent findings show that they also form IL-17A–IL-17F heterodimer”
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Since they use the same receptor complex, IL-17A, -AF and -F trigger qualitatively similar signaling pathways, however IL-17A homodimers induce a far more potent signal compared to IL-17F homodimers, with IL-17AF thought to be intermediate signaling strength (Chang and Dong, 2007; Wright et al., 2007).”
BackgroundTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
“IL-17A and IL-17F are both homodimeric cytokines, but recent evidence shows that human and mouse T cells also produce an IL-17A/F heterodimer that has potent inflammatory effects (40, 41).”
BackgroundTH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Regulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739
Th17: the third member of the effector T cell trilogy
Bettelli, E., Korn, T., & Kuchroo, V. K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.020 · Cited by 652
IL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
Saenz, S. A., Taylor, B. C., & Artis, D. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00713.x · Cited by 484
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477
“IL-17A and IL-17F can form both homodimers and heterodimers, all of which signal through a receptor complex composed of IL-17RA and IL-17R”
BackgroundInterleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
“IL-17A and IL-17F are known to act as homodimers or as IL-17A/F heterodimers (Chang and Dong, 2007; Wright et al., 2007).”
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“A recent study revealed that IL-17RD may be a subunit of IL-17A, but it does not bind to IL-17F.(29,31) IL-17RD instead binds to IL-17RA to form a heterodimeric receptor that can only bind to IL-17A/A.”
BackgroundInfluentialThe IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
“The molecular structure and function of IL17F are highly similar to those of IL-17A (74).”
BackgroundAn overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
“duced by Th17 cells (see Section 5 below) also form a heterodimeric cytokine termed IL-17A/F (Table 1) [10,11].”
Liang, S. C., Long, A. J., Bennett, F., Whitters, M. J., Karim, R., Collins, M., Goldman, S. J., Dunussi-Joannopoulos, K., Williams, C. M. M., Wright, J. F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7791 · Cited by 371
“Recently, human and mouse IL-17A and IL-17F have been reported to exist as a heterodimer (23, 24).”
BackgroundMethodInfluentialEvolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368
“IL17A and IL17F are biologically active as homodimers but are also capable of forming IL17A–IL17F heterodimers.(146) IL17A and IL17F homodimers, as well as the IL17A–IL17F heterodimer, bind with varying affinities to a heterodimeric receptor complex composed of IL17RA and IL17RC.”
BackgroundInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F
Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5462 · Cited by 352
“It has also been recently noted that hIL-17A and -F can be secreted as a heterodimeric complex from Th17 cells (36).”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
Gaffen, S. L., & Hajishengallis, G. (2008) · Journal of Dental Research · doi:10.1177/154405910808700908 · Cited by 334
“Not surprisingly, the IL-17A/F heterodimer signals with intermediate potency (Chang and Dong, 2007; Wright et al., 2007).”
Seiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329
Kumar, P., Monin, L., Castillo, P., Elsegeiny, W., Horne, W., Eddens, T., Vikram, A., Good, M., Schoenborn, A. A., Bibby, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.007 · Cited by 326
“It has been reported that IL-17F responses are 10- to 30-fold weaker than IL-17A; however, the IL-17A-IL-17F heterodimer can signal (McAllister et al., 2005; Wright et al., 2007).”
The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex
Wright, J. F., Bennett, F., Li, B., Brooks, J., Luxenberg, D. P., Whitters, M. J., Tomkinson, K. N., Fitz, L. J., Wolfman, N. M., Collins, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2799 · Cited by 316
“Conservation of the disulfide linkage in both the IL-17A homodimer and the IL-17F/ IL-17A heterodimer suggests that these cytokines have similar structures (20).”
BackgroundMethodResultInfluentialTh17-mediated inflammation in asthma
Newcomb, D. C., & Peebles, R. S. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.08.002 · Cited by 315
“IL-17A forms a homodimer or heterodimer with IL-17F and signals though the IL-17RA/IL-17RC receptor complex [7].”
BackgroundIL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
“a heterodimer with intermediate signaling capacity (78).”
Pappu, R., Ramirez-Carrozzi, V., & Sambandam, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03465.x · Cited by 281
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
“IL-17A is considered the primary effector cytokine of theTh17 lineage, but it also shares a 55% identity to IL-17F [58]; both are capable of forming homodimers or combining to form heterodimers [59, 60].”
BackgroundShen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
“[34] Wright JF, Guo Y, Quazi A, Luxenberg DP, Bennett F, Ross JF,”
BackgroundZhong, Z., Su, G., Kijlstra, A., & Yang, P. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100866 · Cited by 247
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
“They function either as a homodimer or heterodimer and signal through a heterodimeric receptor complex that consists of IL-17 receptor A (IL-17RA) and IL-17RC (Chang and Dong, 2007; Chen and Kolls, 2017; Ely et al., 2009; Fossiez et al., 1996; Gaffen, 2009; Gu et al., 2013; Hymowitz et al., 2001; Kuestner et al., 2007…”
BackgroundTh17 cytokines and their emerging roles in inflammation and autoimmunity
Fouser, L. A., Wright, J. F., Dunussi‐Joannopoulos, K., & Collins, M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00712.x · Cited by 246
Th17 cytokines and mucosal immunity
Dubin, P. J., & Kolls, J. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00703.x · Cited by 244
“and their function is currently being studied (11, 12).”
BackgroundIL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
“expressed receptors, IL-17RA, IL-17RC, or IL-17RA/IL-17RC, respectively [1,23–26].”
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
IL-17–producing T cells in lung immunity and inflammation
Nembrini, C., Marsland, B. J., & Kopf, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.033 · Cited by 210
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
“On the basis of the crystal structure of IL-17F, the six structurally related IL-17 cytokines (IL-17A through IL-17F) are predicted to form a homodimeric fold (or heterodimeric fold in the case of IL-17A–IL-17F) homologous to that of the cysteine-knot growth factors such as nerve growth factor (NGF”
BackgroundBimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F
Adams, R., Maroof, A., Baker, T., Lawson, A. D. G., Oliver, R., Paveley, R., Rapecki, S., Shaw, S., Vajjah, P., West, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01894 · Cited by 188
“Expressed as homodimers, or as a heterodimer (IL-17A/F) (8, 9), both IL-17A and IL-17F signal through the same heterodimeric complex of IL-17 receptors A and C (IL-17RA/RC) (10).”
BackgroundThe Potential Role of Interleukin-17 in Severe Asthma
Wang, Y.-H., & Wills-Karp, M. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0210-y · Cited by 171
“Given that Th17-derived cytokines such as IL-17A and IL-17F are important regulators of neutrophilic inflammation, it has been postulated that aberrant IL-17A/F production may drive severe forms of the disease.”
BackgroundIL-17F: Regulation, signaling and function in inflammation
Chang, S. H., & Dong, C. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.024 · Cited by 169
Zrioual, S., Ecochard, R., Tournadre, A., Lenief, V., Cazalis, M.-A., & Miossec, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801967 · Cited by 169
“These observations are consistent with previous studies reporting higher levels of IL-17F secretion compared with IL-17A upon stimulation of CD4 T cells (10, 14, 45).”
ResultIL-23 and Th17 cytokines in intestinal homeostasis
Maloy, K. J., & Kullberg, M. C. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.28 · Cited by 166
Butcher, M. J., Gjurich, B. N., Phillips, T., & Galkina, E. V. (2012) · Circulation Research · doi:10.1161/circresaha.111.261784 · Cited by 165
Robert, M., & Miossec, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2018.00364 · Cited by 165
“Among the IL-17 family, IL-17A and IL-17F share the greatest homology with a 50% sequence identity and can be secreted as homodimer or heterodimer (15, 16).”
BackgroundRole of IL-17 in Psoriasis and Psoriatic Arthritis
Raychaudhuri, S. P. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8307-1 · Cited by 160
“Some studies also showed that human and mouse T cells also produce IL-17A/F, heterodimer, which has potent inflammatory potential [57, 58].”
BackgroundHu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 153
IL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett-Sinha, L. A., John, S., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 150
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 154
Crystal structures of interleukin 17A and its complex with IL-17 receptor A
Liu, S., Song, X., Chrunyk, B. A., Shanker, S., Hoth, L. R., Marr, E. S., & Griffor, M. C. (2013) · Nature Communications · doi:10.1038/ncomms2880 · Cited by 165
Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
A Protective Role by Interleukin-17F in Colon Tumorigenesis
Tong, Z., Yang, X. O., Yan, H., Liu, W., Niu, X., Shi, Y., Fang, W., Xiong, B., Wan, Y., & Dong, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034959 · Cited by 160
“could form homodimers or heterodimers with IL-17A in both human and mice [7,8].”
BackgroundThe role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
Paulissen, S. M. J., van Hamburg, J. P., Dankers, W., & Lubberts, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.002 · Cited by 155
Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 154
Kim, J., Lee, J., Kim, H. J., Kameyama, N., Nazarian, R., Der, E., Cohen, S., Guttman-Yassky, E., Putterman, C., & Krueger, J. G. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.021 · Cited by 140
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Shin, J. H., Shin, D. W., & Noh, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.008 · Cited by 144
TH17 cells and corticosteroid insensitivity in severe asthma
Xie, Y., Abel, P. W., Casale, T. B., & Tu, Y. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.12.769 · Cited by 151
Regulation of epithelial immunity by IL-17 family cytokines
Pappu, R., Rutz, S., & Ouyang, W. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.008 · Cited by 142
Wong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“IL-17A and IL-17F can be secreted as homodimers and heterodimers which have overlapping but distinct proinflammatory functions and differing potency, with more strength and effects attributed to IL-17A (Ishigame et al., 2009; Liang et al., 2007; Wright et al., 2007; Yang et al., 2008).”
BackgroundThe deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
The IL-17 Family Cytokines in Immunity and Disease
Pappu, R., Ramirez-Carrozzi, V. R., Ota, N., Ouyang, W., & Hu, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9369-6 · Cited by 142
“This difference in binding affinities is in accord with the potency of each of the cytokine dimers [6, 11].”
BackgroundResultInfluentialRoeleveld, D. M., & Koenders, M. I. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.006 · Cited by 140
“IL-17A and IL-17F can be secreted as homodimer or heterodimer (IL-17A/F) [33] and bind to the IL-17 receptor (IL-17R) complex that is widely expressed throughout the body.”
BackgroundRegulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 125
“We, as well as others, have shown that IL-17 and IL-17F form a biologically active heterodimer with intermediate potency when compared with homodimers in inducing inflammatory genes (18, 19).”
BackgroundInflammatory cytokines in pediatric obstructive sleep apnea
Huang, Y., Guilleminault, C., Hwang, F., Cheng, C., Lin, C.-H., Li, H., & Lee, L. (2016) · Medicine · doi:10.1097/md.0000000000004944 · Cited by 134
TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
Marwaha, A. K., Leung, N. J., McMurchy, A. N., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00129 · Cited by 120
“IL-17A can combine with IL-17F to form a heterodimer and both can form homodimers (Wright et al., 2007).”
BackgroundEmerging Role of IL-17 in Atherosclerosis
Chen, S., Crother, T. R., & Arditi, M. (2010) · Journal of Innate Immunity · doi:10.1159/000314626 · Cited by 119
“Both IL-17A and IL-17F act as homodimers, but an IL-17A/F heterodimer has been described recently [ ,”
BackgroundTargeting the Th17 pathway in psoriasis
Elloso, M. M., Gómez-Angelats, M., & Fourie, A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212101 · Cited by 117
“shown to form heterodimers with IL-17F [11–13].”
BackgroundInterleukin-17 as a drug target in human disease
Ivanov, S., & Lindén, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.004 · Cited by 123
CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease
Chang, Y., Nadigel, J., Boulais, N., Bourbeau, J., Maltais, F., Eidelman, D. H., & Hamid, Q. A. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-43 · Cited by 109
“IL-17A and IL17F display high sequence homology and can be secreted as homodimers, as well as IL-17A/F heterodimers, by both mouse and human cells [7,8].”
BackgroundKellner, H. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13485328 · Cited by 109
The IL-23/IL-17 pathway in inflammatory bowel disease
Geremia, A., & Jewell, D. P. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.107 · Cited by 123
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
“The difference between these three ligands is mainly in the potency of interaction: IL17A>IL-17A-IL-17F> IL-17F (74).”
BackgroundIL-17RC: a partner in IL-17 signaling and beyond
Ho, A. W., & Gaffen, S. L. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0185-0 · Cited by 104
“The IL-17A homodimer was found to be the most potent IL-17 family effector molecule based on its induction of the target gene CXCL1, followed by the IL17A/F heterodimer, and finally the IL-17F homodimer [15].”
Morrison, P. J., Ballantyne, S. J., & Kullberg, M. C. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03454.x · Cited by 116
Smith, E., Stark, M. A., Zarbock, A., Burcin, T. L., Bruce, A. C., Vaswani, D., Foley, P., & Ley, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1357 · Cited by 101
Gut Microbiota Regulates K/BxN Autoimmune Arthritis through Follicular Helper T but Not Th17 Cells
Block, K. E., Zheng, Z., Dent, A. L., Kee, B. L., & Huang, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501904 · Cited by 99
“We crossed an Il17a-deficient strain (Cre recombinase is knocked into the IL-17A locus before the ATG start codon, inactivating the IL-17A expression) (20) to KRN TCR transgenic and to B6.”
InfluentialInterleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models
Zhang, Q., Liu, S., Ge, D., Zhang, Q., Xue, Y., Xiong, Z., Abdel-Mageed, A. B., Myers, L., Hill, S. M., Rowan, B. G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3795 · Cited by 98
IL-13 Regulates Th17 Secretion of IL-17A in an IL-10–Dependent Manner
Newcomb, D. C., Boswell, M. G., Huckabee, M. M., Goleniewska, K., Dulek, D. E., Reiss, S., Lukacs, N. W., Kolls, J. K., & Peebles, R. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102216 · Cited by 98
“IL-4, which activates STAT6, also negatively regulated IL-17A and IL-17F expression (13, 14, 17) in vivo.”
BackgroundInfluentialThe human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
Goepfert, A., Lehmann, S., Wirth, E., & Rondeau, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08360-9 · Cited by 107
Zheng, X., de Paiva, C. S., Li, D., Farley, W. J., & Pflugfelder, S. C. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3838 · Cited by 97
A tale of two cytokines: IL-17 and IL-22 in asthma and infection
Manni, M. L., Robinson, K. M., & Alcorn, J. F. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.854167 · Cited by 101
Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity
Mai, J. (2010) · Frontiers in Bioscience · doi:10.2741/3657 · Cited by 93
“IL17F is found to be expressed at the highest concentration followed by IL17A/F heterodimer whereas IL-17 homodimer detection is minimal in activated T cells from human donor (51).”
BackgroundIsolation of seven IL-17 family genes from the Japanese pufferfish Takifugu rubripes
Korenaga, H., Kono, T., & Sakai, M. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.01.016 · Cited by 91
Awang, R. A., Lappin, D. F., MacPherson, A., Riggio, M. P., Robertson, D. P., Hodge, P. J., Ramage, G., Culshaw, S., Preshaw, P. M., Taylor, J. J., et al. (2014) · Inflammation Research · doi:10.1007/s00011-014-0776-7 · Cited by 98
IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
Nies, J. F., & Panzer, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00341 · Cited by 104
“Structurally, all members of the IL-17 cytokine family are homodimers in their biologically active form, yet one heterodimer consisting of IL-17A and IL-17F (IL-17A/F) is described (5, 6).”
BackgroundTargeting interleukin-17 in chronic inflammatory disease: A clinical perspective
Zwicky, P., Unger, S., & Becher, B. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191123 · Cited by 91
Kurimoto, E., Miyahara, N., Kanehiro, A., Waseda, K., Taniguchi, A., Ikeda, G., 古賀, 光., Nishimori, H., Tanimoto, Y., Kataoka, M., et al. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-5 · Cited by 95
“and human cells [11].”
Targeting the development and effector functions of TH17 cells
Ghilardi, N., & Ouyang, W. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.016 · Cited by 106
Kumar, P., Natarajan, K., & Shanmugam, N. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.031 · Cited by 94
Yeremenko, N. G., Paramarta, J. E., & Baeten, D. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000069 · Cited by 104
“IL-17A and IL-17F are both covalent homodimers, but the single subunits can also form IL-17A–IL-17F heterodimers [11].”
BackgroundTH17 cells in asthma and inflammation
Aujla, S. J., & Alcorn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.002 · Cited by 103
The role of interleukin-17 in asthma: a protective response?
Hynes, G., & Hinks, T. (2020) · ERJ Open Research · doi:10.1183/23120541.00364-2019 · Cited by 103
Targeting IL-17 and Th17 Cells in Rheumatoid Arthritis
Sarkar, S., & Fox, D. A. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.02.006 · Cited by 89
“IL17A and IL-17F are both homodimeric cytokines, but human and mouse T cells also produce an IL-17A/F heterodimer that has potent inflammatory effects.(37,38) It may be important to measure, as well as to target, both IL-17A and IL-17F in disease.”
Structure of IL-17A in Complex with a Potent, Fully Human Neutralizing Antibody
Gerhardt, S., Abbott, W. M., Hargreaves, D., Pauptit, R. A., Davies, R. A., Needham, M., Langham, C., Barker, W., Aziz, A., Snow, M. J., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.008 · Cited by 89
“It has also been shown that IL-17A and IL-17-F can form functional heterodimers in human T-cells and can induce neutrophilia in a murine adoptive transfer model.(6,7) Recent studies have identified Th17 cells as a unique and distinct CD4 T-cell lineage that is defined by the production of IL-17A, IL-17F, IL-6, tumor n…”
BackgroundStructure and function of interleukin-17 family cytokines
Zhang, X., Angkasekwinai, P., Dong, C., & Tang, H. (2011) · Protein & Cell · doi:10.1007/s13238-011-1006-5 · Cited by 96
IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling
Rong, Z., Wang, A., Li, Z., Ren, Y., Cheng, L., Li, Y., Wang, Y., Ren, F., Zhang, X., Hu, J., et al. (2008) · Cell Research · doi:10.1038/cr.2008.320 · Cited by 86
Role of IL-17A in Neutrophil Recruitment and Hepatic Injury after Warm Ischemia–Reperfusion Mice
Kono, H., Fujii, H., Ogiku, M., Hosomura, N., Amemiya, H., Tsuchiya, M., & Hara, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100490 · Cited by 77
“Recent studies showed that the IL-17A/F heterodimer is more potent than IL-17F homodimer but less potent than IL-17A homodimer in inducing chemokine expression (15, 16).”
Background
Metadata
- Authors
- Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., Carreno, B. M., Collins, M., & Wolfman, N. M.
- Affiliations
- Wyeth (US)
- Corresponding author
- Carreno, Beatriz M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 18
- Pages
- 13447-13455
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2091653067
- Cited by
- 319
- References
- 36
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 9 · 2017: 16 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 21 · 2012: 25
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4932 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17F, IL-17A, CD4+ T cells, T cell activation, cytokine structure, T cell immunity, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Cricetulus, Cysteine, Gene Expression Regulation, Cricetinae, Humans, Immunity, Cellular, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Gene Expression, CHO Cells, Dimerization, Interleukin-17, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.